Engineers in Prof. James Harris' laboratory have developed a compact optics and microfluidics device to continuously monitor the hemostatic state of patients undergoing heart surgery, dialysis or other procedures.
Stanford researchers at the Airan Lab have developed a new method for robust and spatiotemporally precise non-invasive neuromodulation that could transform both basic and clinical neuroscience.
Researchers in Dr. Michelle Monje-Deisseroth's lab at Stanford have recently identified therapeutic targets for drug development to limit the spread of high-grade gliomas (HGGs).
Transgenic mice carrying reporter genes are extremely useful tools in modern biomedical science to unravel various underlying molecular mechanisms crucial for normal development, as well as, disease progression.
Researchers at the Solgaard Lab have demonstrated that light sheet fluorescence microscopy (LSFM) with structured and pivoting illumination enables fast image acquisition and improved image quality.
Stanford researchers have developed a quantitative, noninvasive, and early predictor of viability at the early embryo and oocyte stage using mechanical biomarkers.
Researchers at Stanford have developed methods for preparing photo-, and chemical-, cross-linkable three-dimensional matrices for the controlled delivery of bioactive molecules for therapeutic applications.
Stanford researchers have invented a novel concept to prevent or minimize scar formation during injury by controlling the mechanical environment through molecular targeting of mechanotransduction sensors including focal adhesion kinase (FAK).
Researchers in Prof. Karl Deisseroth's laboratory have developed an optical imaging and optogenetics two photon laser system that uses a single beam to illuminate many sites in three-dimensions.
Stage of research
Researchers designed electro-optical gratings for fluorescence microscopy - a drop in to existing systems with no new lenses. Researchers demonstrate a 9x improvement on FOV using Olympus 10x/0.6NA WI immersion objective at 3.3 Hz.
Researchers in Prof. Karl Deisseroth's laboratory have engineered versatile, virus-based constructs that are driven by neuronal activity to either label or optogenetically control those active neurons.
Stanford researchers have developed a method that can tune the ratio between reversible (RE) and irreversible (IRE) electroporation through waveform adjustments.
Researchers at Stanford have developed a ferumoxytol-based dual-modality imaging probe that allows for long-term stem cell tracking through MRI and early diagnosis of cell apoptosis through simultaneous fluorescence imaging.
Richard Zare's lab at Stanford University has developed a ground-breaking drug release system in which injected medication can be controlled externally with excellent spatial, temporal, and dosage control.